Dura Pharmaceuticals Inc. announced Thursday that it hassigned a letter of intent to sell the assets of its devices divisionto Pari Respiratory Equipment Inc. of Richmond, Va.

With the sale of the devices, which include compressors andnebulizers, Dura of San Diego now intends to concentrate itsresources on prescription pharmaceuticals for treating asthma,allergies and related respiratory conditions.

In fact, Dura (NASDAQ:DURA) will funnel the proceeds of thissale into its core business and expand its sales force .

(c) 1997 American Health Consultants. All rights reserved.